Assenagon Asset Management S.A.
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in RYTM
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$20,706,095
-$1,928,591 QoQ
Shares Held
186,491
-16.8% QoQ
Ownership
0.271%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#57
of 299 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. RYTM ranks #24 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in RYTM
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,706,095 | 186,491 | Shares | Sole | 2026-08-21 | |
| 2025-09-30 | $22,634,686 | 224,128 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $15,039,093 | 237,998 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,175,510 | 22,192 | Shares | Sole | 2025-04-15 | |
| 2024-09-30 | $1,050,524 | 20,052 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $9,422,900 | 229,491 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $12,377,257 | 285,651 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $13,866,206 | 301,636 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $9,337,123 | 407,290 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $8,957,532 | 543,210 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $11,846,223 | 664,026 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $13,497,585 | 463,516 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $11,525,045 | 470,410 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $2,862,338 | 689,720 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $8,132,198 | 705,920 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $6,833,765 | 684,746 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $6,559,646 | 502,270 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $2,789,601 | 142,472 | Shares | Sole | 2021-07-15 | |
| No filing history on record for this holder in this stock. | ||||||